Found: 6
Select item for more details and to access through your institution.
Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-29688-5
- By:
- Publication type:
- Article
Pantothenate and CoA biosynthesis in Apicomplexa and their promise as antiparasitic drug targets.
- Published in:
- PLoS Pathogens, 2021, v. 17, n. 12, p. 1, doi. 10.1371/journal.ppat.1010124
- By:
- Publication type:
- Article
Characterization of P. falciparum dipeptidyl aminopeptidase 3 specificity identifies differences in amino acid preferences between peptide‐based substrates and covalent inhibitors.
- Published in:
- FEBS Journal, 2019, v. 286, n. 20, p. 3998, doi. 10.1111/febs.14953
- By:
- Publication type:
- Article
Plasmodium falciparum dipeptidyl aminopeptidase 3 activity is important for efficient erythrocyte invasion by the malaria parasite.
- Published in:
- PLoS Pathogens, 2018, v. 14, n. 5, p. 1, doi. 10.1371/journal.ppat.1007031
- By:
- Publication type:
- Article
Identification of Plasmodium dipeptidyl aminopeptidase allosteric inhibitors by high throughput screening.
- Published in:
- PLoS ONE, 2019, v. 14, n. 12, p. 1, doi. 10.1371/journal.pone.0226270
- By:
- Publication type:
- Article
Antimalarial pantothenamide metabolites target acetyl–coenzyme A biosynthesis in Plasmodium falciparum.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 510, p. 1, doi. 10.1126/scitranslmed.aas9917
- By:
- Publication type:
- Article